Biohaven Pharmaceutical Holding Company Ltd.
Open: 12:46 PM
BHVN Stock Price Graph
BHVN Stock Price Today
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stock rallied over 0.15% intraday to trade at $33.06 a share on NYSE. The stock opened with a loss of -14.87% at $28.10 and touched an intraday high of $28.20, rising 0.15% against the last close of $33.01. The Biohaven Pharmaceutical Holding Company Ltd. in stock market went to a low of $26.69 during the session.
BHVN Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
BHVN Stock Price History Chart
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.
Frequently Asked Questions
What is the current Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stock price?
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) stock price is $33.06 in the last trading session. During the trading session, BHVN stock reached the peak price of $28.20 while $26.69 was the lowest point it dropped to. The percentage change in BHVN stock occurred in the recent session was 0.15% while the dollar amount for the price change in BHVN stock was $0.05.
BHVN's industry and sector of operation?
The NYSE listed BHVN is part of Biotechnology industry that operates in the broader Healthcare sector. Biohaven Pharmaceutical Holding Company Ltd. , a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States.
Who are the executives of BHVN?
Dr. Vladimir Coric M.D.
Chairman & Chief Executive Officer
Mr. Chris Barrett
Senior Vice President of Commercial Strategy, Common Disease
Mr. George C. Clark
Vice President & Chief Accounting Officer
Mr. Chris Barrett
Sr. VP of Commercial Strategy, Common Disease
How BHVN did perform over past 52-week?
BHVN's closing price is 1.48% higher than its 52-week low of $12.35 where as its distance from 52-week high of $28.85 is -0.33%.
How many employees does BHVN have?
Number of BHVN employees currently stands at N/A. BHVN operates from 215 Church Street, New Haven, CT 06510, US.
Link for BHVN official website?
Official Website of BHVN is: https://www.biohavenpharma.com
How do I contact BHVN?
How many shares of BHVN are traded daily?
BHVN stock volume for the day was 1067428.00 shares. The average number of BHVN shares traded daily for last 3 months was 1.22 Million.
What is the market cap of BHVN currently?
The market value of BHVN currently stands at $2.26 Billion with its latest stock price at $33.06 and N/A of its shares outstanding.